Krejbich F, Trnka L, Mazánková V
Národní jednotka dohledu nad tuberkulózou-Klinika pneumologie a hrudní chirurgie, Praha.
Cas Lek Cesk. 2003;142(12):746-50.
The number of all notified TB cases decreased in the year 2002. 1200 (11.8/100,000) cases of new TB diseases and relapses were reported in the year 2002. 972(9.6/100,000) were pulmonary TB and from them 658 (6.4/100,000) were confirmed pulmonary cases.
The decreasing trend in TB incidence, reported since 1999, has continued. The treatment of confirmed pulmonary cases notified in 2001 and evaluated in 2002 was effective. Treatment success was in 71% of cases, but failures and interrupted were only 3.3%. Results of treatment were affected by many patients who died for other reason then TB, because they were from the oldest group of population. We have no influence on these deaths. The resistance for AT drugs was less then 7% and MDR cases were less the 2%.
The low level of resistance and the effectiveness of treatment allow presuming a further decrease of TB cases. Next target of TB control should be active case finding in high-risk groups and monitoring latent infection.
2002年所有通报的结核病病例数有所下降。2002年报告了1200例（11.8/10万）新发结核病病例和复发病例。972例（9.6/10万）为肺结核，其中658例（6.4/10万）为确诊肺结核病例。
自1999年以来报告的结核病发病率下降趋势仍在持续。对2001年通报并于2002年评估的确诊肺结核病例的治疗是有效的。治疗成功率为71%，但失败和中断治疗的仅占3.3%。治疗结果受到许多因结核病以外其他原因死亡的患者的影响，因为他们来自最年长的人群组。我们对这些死亡情况无法施加影响。对一线抗结核药物的耐药率低于7%，耐多药病例低于2%。
低耐药水平和治疗效果使得可以推测结核病病例数将进一步下降。结核病控制的下一个目标应是在高危人群中积极发现病例并监测潜伏感染。
